This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase II study with capecitabine as monotherapy in...
Clinical trial

Phase II study with capecitabine as monotherapy in the treatment of platinum resistant or refractory ovarian cancer

Read time: 1 mins
Last updated:23rd Jun 2006
To evaluate the activity and the toxicity of capecitabine as monotherapy in the treatment of platinum resistant or refractory ovarian cancer
Category Value
Study start date 2006-06-23

View full details